21/01/2021

IMIBIC CALL FOR EoI. POST-DOCTORAL RESEARCHERS: Sara Borrell contracts 2021 - Research group GC17 Physiopathology of Endocrine Vitamin D System Biotechnology and Aging

This hosting has expired


  • OFFER DEADLINE
    04/02/2021 23:30 - Europe/Brussels
  • EU RESEARCH FRAMEWORK PROGRAMME
    Not funded by an EU programme
  • LOCATION
    Spain, Córdoba
  • ORGANISATION/COMPANY
    Maimonides Biomedical Research Institute of Cordoba - IMIBIC
  • LABORATORY
    GC17

IMIBIC CALL FOR Expressions of Interest

Postdoctoral Researchers: Sara Borrell contracts 2021

Research group GC17 Physiopathology of Endocrine Vitamin D System Biotechnology and Aging

Reference: 008/2021

 

Aim of the call:

The research group GC17 Physiopathology of Endocrine Vitamin D System Biotechnology and Aging, led by Dr. José Manuel Quesada Gómez, is looking for suitable candidates to apply for the SARA BORRELL Fellowships. The selected candidate will apply for the fellowship under the supervision of Dr. Antonio Casado Díaz (Nicolás Monardes Researcher).

The selected candidate would work in the research of mesenchymal stem cells or exosomes in the context of regenerative medicine, or with the development of new strategies for the identification of biomarkers in circulating exosomes and their application in the diagnosis and prognosis of patients with pathologies associated with aging and frailty.

Sara Borrell Fellowships are funded by the National Institute of Health Carlos III (ISCIII), via the Strategic Action in Health 2021 (Acción Estratégica en Salud). They offer a 3 years employment contract for postdoctoral researchers.

Supervisor: Dr. Antonio Casado Díaz: http://orcid.org/0000-0002-8520-8278

Information about the Group: https://www.imibic.org/grupo/32

Deadline for Expressions of Interest: 4th of February 2021.

Application deadline: 3rd March 2021

 

Candidate profile:

Minimum requirements:

  • Masters degree and PhD in Biomedicine / Life Sciences, or related áreas (Biology, Biochemistry, Pharmacy, Medicine, etc.) Important. The PhD must be obtained after the 1st of January 2017.
  • Previous experience in biomedical researchers, especially in the areas of genomics and proteomics
  • High level of written and spoken English and good scientific communication skills

Valued merits:

  • Number and quality of publications and other scientific contributions o awards, international experience, and research stays.
  • Motivation, creativity, ability to cooperate, and teamwork skills.

 

Further information:

Call info and documents: https://www.isciii.es/QueHacemos/Financiacion/Solicitudes/Paginas/defaul...

Call Rules, including applicant requirements and evaluation criteria: https://www.isciii.es/QueHacemos/Financiacion/solicitudes/Documents/AES%...

(see “Subsección 3ª. Contratos Sara Borrell" As of page 61).

 

How to present your candidacy:

Interested candidates should send their CV, motivation letter, academic grades, and if possible, 2 recommendation letters from current or previous supervisors.

Apply via email: personal@imibic.org and indicate the reference "008/2021" in the email subject.

Important: The CV should specify the previous experience in months to allow correct evaluation of valued merits. Applicants failing to do so will not be evaluated.

Deadline for Expressions of interest: 4th Feb 2021.

 

Selection Process:

The process will consist of an eligibility check an evaluation of the merits of all CVs received. The best-positioned candidates may be called for a personal interview in order to evaluate more precisely their skills.

 

Description of IMIBIC:

The Maimonides Biomedical Research Institute of Cordoba, IMIBIC, located in Cordoba, southern Spain, is a partnership between the University of Cordoba and the Reina Sofia University Hospital. IMIBIC offers a multidisciplinary environment focused on results-oriented research and based on precision medicine and excellence in science. IMIBIC is accredited with the Excellence distinction from the Spanish National Institute of Health Carlos III and has the HR Excellence in Research Award of the European Commission.

The Institute is structured in research groups that cooperate in the implementation of 5 core scientific programmes: Active aging and Frailty; Nutrition and endocrine and metabolic diseases; Infectious and immunological diseases and organ transplantation; Cancer; and Chronic and Inflammatory Diseases. Our major goal is to promote biomedical innovation as a powerful engine for economic and social development. To this end, the Institute offers an active environment in which to conduct high-level scientific research. Regular seminars and research events offer the opportunity to meet with national and international speakers covering a diverse range of topics in biomedicine.

IMIBIC is a young and fast-growing research institution; since 2015 it operates in the brand new IMIBIC building for basic and translational research which is strategically located within the University Health Sciences Campus, next to the Reina Sofia University Hospital. It hosts a wide variety of core facilities for researchers, including the Biomedical Research Support Units with brand new equipment and laboratories to support the technical needs of the IMIBIC community, as well as a Clinical Research Unit to support clinical trial studies. IMIBIC currently hosts over 600 researchers, of which nearly 400 combine their research activities with patient care.

 

Disclaimer:

The responsibility for the hosting offers published on this website, including the hosting description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.